Valuation Sernova Biotherapeutics Inc
Stocks
SVA
CA81752F1062
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Toronto S.E.
10/09/2026
|
5-day change | 1st Jan Change | ||
| 0.1400 CAD | 0.00% |
|
+21.74% | +7.69% |
Company Valuation: Sernova Biotherapeutics Inc
Data adjusted to current consolidation scope
| Fiscal Period: October | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 326.4 | 234.5 | 243.9 | 81.33 | 59.26 | 52.87 | - | - |
| Change | - | -28.16% | 3.99% | -66.65% | -27.14% | -10.78% | - | - |
| Enterprise Value (EV) | 326.4 | 234.5 | 235.1 | 75.79 | 63.76 | 52.87 | 52.87 | 52.87 |
| Change | - | -28.16% | 0.27% | -67.77% | -15.87% | -17.08% | 0% | 0% |
| P/E | -41.7x | -8.89x | -5.85x | -2.5x | -3x | -5.6x | -4.67x | -2.8x |
| PBR | - | - | 18.4x | -6.28x | -1.96x | -4.67x | -3.5x | 0.41x |
| PEG | - | -0x | -0.1x | 0.1x | 0.1x | 0.1x | -0.2x | -0x |
| Capitalization / Revenue | - | - | - | - | - | - | 21.1x | 0.41x |
| EV / Revenue | - | - | - | - | - | - | 21.1x | 0.41x |
| EV / EBITDA | - | - | - | - | - | - | - | - |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -5.75x | -4.44x | -2.8x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.03 | -0.09 | -0.13 | -0.1 | -0.05 | -0.025 | -0.03 | -0.05 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | - | - | - | - | - | - | 2.5 | 127.8 |
| EBITDA | -6.669 | -24.31 | -40.06 | -31.12 | -14.68 | - | - | - |
| EBIT 1 | -6.937 | -24.75 | -40.5 | -31.66 | -15.02 | -9.2 | -11.9 | -18.9 |
| Net income 1 | -6.966 | -24.42 | -39 | -32.19 | -15.74 | -11.3 | -13.9 | -20.9 |
| Net Debt | - | - | -8.722 | -5.544 | 4.503 | - | - | - |
| Reference price 2 | 1.2500 | 0.8000 | 0.7600 | 0.2500 | 0.1500 | 0.1400 | 0.1400 | 0.1400 |
| Nbr of stocks (in thousands) | 261,133 | 293,125 | 320,857 | 325,325 | 395,037 | 377,643 | - | - |
| Announcement Date | 14/02/22 | 26/01/23 | 29/01/24 | 23/12/24 | 19/12/25 | - | - | - |
1CAD in Million2CAD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| -5.6x | - | - | - | 38.26M | ||
| 20.98x | 4.13x | 14.41x | 1.33% | 104B | ||
| 17.45x | 2.24x | 8.69x | 2.94% | 11.67B | ||
| -210.63x | 14.29x | 1696.21x | -.--% | 10.04B | ||
| 21.19x | 9.76x | 16.89x | 1.95% | 3.99B | ||
| 23.85x | - | - | - | 2.4B | ||
| -1580.51x | 1.91x | 8.94x | -.--% | 1.97B | ||
| 16.32x | 4.26x | 8.33x | 3.75% | 1.53B | ||
| Average | -212.12x | 6.10x | 292.25x | 1.66% | 16.9B | |
| Weighted average by Cap. | -19.86x | 4.87x | 141.07x | 1.4% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- SVA Stock
- Valuation Sernova Biotherapeutics Inc
Select your edition
All financial news and data tailored to specific country editions
















